MicrobiologybioRxivPreprint
Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models
A. Petcherski, M. Sharma, S. Satta…·T. Kelesidis
Mitoquinone mesylate shows antiviral and anti-inflammatory effects against SARS-CoV-2 in preclinical models.
DOI 10.1101/2022.02.22.481100